Professor Fernando Figueira Integral Medicine Institute
This is a randomized controlled clinical trial with hospitalized infants in the Professor Fernando Figueira Medicine Institute(IMIP), who require phototherapy as an indication of the medical team. Following the sample calculation, 144 patients will be randomized according to gestational age (350/7-376/7 or 380/7-416/7 weeks) to receive super-LED reverse phototherapy or fluorescent reverse phototherapy with spectral irradiance of 8-12 microwatts/cm2/nm.The bilirubin will be determined by micromethod with bilirubinometer, after blood collection in heparinized capillary until bilirubin reaches level that indicates suspension of therapy.
Age
0–0
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Newborns in the maternity Professor Fernando Figueira Medicine Institute(IMIP)
Gestational age between 350/7 and 416/7 weeks
Birth weight greater than 2200g
Absence of congenital malformations
indication of phototherapy after 48 hours of life
Terms of consent signed by parent or guardian
You may not be if
Total Bilirubin level indicative of phototherapy intensive or exchange transfusion
RH incompatibility hemolytic disease
Mother's refusal to continue to participate in the study
Unavailability of the two types of phototherapy equipment for randomization